European Companies Search Engine
Managing Director (1) · Merger: Mibe GmbH Arzneimittel Hrb 19 Jan 2007 German Trade Register Announcements, Germany (10/01/2007)
Overview
Text
LABOPOINT Gesellschaft für Analytik und pharmazeutische Verfahrenstechnik mbH, Mainz (
Unnamed street ??, 55126 Mainz, Germany
). Appointed as Managing Director: ?????, ???????, Grünwald, *??.??.????, authorized to enter into legal transactions on behalf of the company with the power to represent itself or as a representative of a third party. The company is merged as a transferring entity with the Mibe GmbH Arzneimittel with its registered office in Brehna (Amtsgericht Stendal HRB 16486) in accordance with the merger agreement of December 6, 2006 as well as the approval decisions of its shareholders' meeting of 06.012.2006 and the shareholders' meeting of the acquiring entity of December 6, 2006 with the Mibe GmbH Arzneimittel with its registered office in Brehna (Amtsgericht Stendal HRB 16486). The merger shall only become effective upon registration on the register sheet of the acquiring entity. The creditors of the companies participating in the merger must be deemed to have declared their claim in writing in writing within six months of the date on which the registration of the merger in the register of the registered office of the entity of which they are creditors is deemed to have been made known in accordance with Paragraph 19 (3) of the UmwG, provided that they cannot claim satisfaction. However, creditors are only entitled to this right if they demonstrate that the merger jeopardises the fulfilment of their claim.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: LABOPOINT Gesellschaft für Analytik und pharmazeutische Verfahrenstechnik mbH, Mainz, Germany.